Lung Cancer Awareness: Advancements in Diagnosis, Treatment, and Prevention Strategies

Tütün kullanımı akciğer kanserinin gelişimindeki en önemli risk faktörü olarak görülürken, dünya genelinde her iki dakikada bir kişiye bu hastalık tanısı konuluyor.

Türkiye’de ise her yıl yaklaşık 38 bin kişiye akciğer kanseri teşhisi konulurken, dünya genelinde yıllık vaka sayısı 2.6 milyona yaklaşıyor; bu hastaların 1.9 milyonu ise hayatını kaybediyor.

• Tobacco consumption, including electronic cigarettes, is the single most significant preventable risk factor for lung cancer development.
• Early detection through low-dose computed tomography (LDCT) significantly improves survival outcomes, particularly for individuals aged 50 to 80 with a 20 pack-year smoking history.
• Modern treatment requires a multidisciplinary approach, integrating surgery, targeted radiation, and personalized medical oncology based on the tumor’s molecular profile.

Akciğer Kanseri Vakaları Ve Nedenleri Artıyor

The global incidence of lung cancer has shifted dramatically over the last century. “Yüzyılın başında akciğer kanseri çok nadir bir tümördü.” Doç.

Dr. Osman Elbek, a chest diseases specialist, said that lung cancer was a rare diagnosis at the start of the 20th century. While smoking is the dominant cause, other environmental factors, including radiation, air pollution, diesel exhaust, and industrial emissions, contribute to the disease’s pathogenesis.

Clinicians emphasize that the risk is not limited to active smokers. Prof. Dr. Muhammed Emin Akkoyunlu told Habertürk that approximately 10% of lung cancer patients have never smoked, which highlights the role of genetic predisposition and environmental exposures. Furthermore, the risk extends to all tobacco-delivery systems, including electronic cigarettes, which continue to be a significant health concern for respiratory specialists.

“Akciğer kanserinin toplumsal bir yönü var. Milyonlarca aileyi etkiliyor ve insanlığı tehdit eden en önemli ölüm nedenlerinin başında geliyor.” Prof. Dr. Muhammed Emin Akkoyunlu said.

According to Doç. Dr. Elbek, the disease has become the leading cause of cancer-related mortality, particularly among men. He stated, “Because the best treatment is to ensure the disease does not form,” emphasizing that eliminating tobacco usage could effectively eradicate the cancer. Medipol Health Group recently highlighted the importance of collaborative efforts in addressing these trends during their “Every Breath is Valuable” panel held on November 13.

Tanı Koymak Için Patolojik Inceleme Gerekiyor

Determining the optimal treatment pathway depends entirely on the accuracy of the initial diagnosis. “Akciğer kanserinde kesin tanı patolojik incelemeyle konuluyor.” Prof. Dr. Cüneyt Saltürk explained to Habertürk that definitive diagnosis requires pathological examination. According to the Turkish Medical Oncology Association, identifying the tumor’s specific genetic characteristics is the essential first step in determining whether a patient is a candidate for targeted therapies.

Advancements in Multidisciplinary Treatment

Prof. Dr. Abdullah Sakin said that the role of medical oncology has expanded significantly, with clinicians now initiating treatments even before surgical intervention to reduce tumor volume. For patients in the fourth stage of the disease, new pharmaceutical options have increased life expectancy and survival rates.

Surgical techniques have similarly progressed toward minimally invasive procedures. Prof. Dr. Mehmet Zeki Günlüoğlu said that surgeons now utilize small incisions and camera-assisted technology to reach the target area, which preserves healthy tissue and improves post-operative recovery. Radiation oncology has also seen technical improvements, allowing for “pinpoint” delivery of radiation that protects surrounding organs, Prof. Dr. Dilek Ünal told Habertürk.

Tarama Protokolleri Ve Yeni TEDAVİ Araştırmaları

The Turkish Medical Oncology Association recommends annual low-dose computed tomography scans for individuals aged 50 to 80 who have a 20 pack-year smoking history. This screening protocol is intended to catch malignancies at an earlier, more treatable stage. While immunotherapy has become a pillar of modern care by helping the immune system identify and combat cancer cells, researchers are still evaluating the efficacy of mRNA-based cancer vaccines.

Doç. Dr. Tülay Eren, a board member of the Turkish Medical Oncology Association, clarified that there is currently no mRNA cancer vaccine with confirmed clinical effectiveness, though it remains an active area of research.

The medical community continues to face the challenge of distinguishing between smoking-related chronic coughs and symptoms indicative of malignancy. Doç. Dr. Elbek said that because many tobacco users suffer from chronic coughs, symptoms of cancer are often masked. He advised, “If there is a cough that lasts longer than three weeks, apply to a physician.”

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.